Baxter Shares: Navigating a Perfect Storm of Challenges

Baxter International Inc. finds its equity trading near annual lows as the medical technology company contends with a confluence of significant legal pressures and operational disruptions. Investors are grappling with whether there remains a viable path to recovery for the embattled firm.

The company is navigating its current challenges amidst a key leadership change. In late October 2025, Heather Knight, who served as Executive Vice President and Chief Operating Officer, departed from Baxter. CEO Andrew Hider has assumed her responsibilities on an interim basis, adding to his workload during an already turbulent period for the organization.

Mounting Legal Liabilities from Infusion Pump Allegations

A central element of Baxter’s Read more...